Application of Pseudo-Three-Dimensional Residual Network to Classify the Stages of Moyamoya Disease

Jiawei Xu1, Jie Wu1, Yu Lei2

  • 1School of Health Science & Engineering, University of Shanghai for Science & Technology, Shanghai 200093, China.

Brain Sciences
|May 27, 2023
PubMed

Insights

A new Pseudo-Three-Dimensional Residual Network (P3D ResNet) accurately identifies moyamoya disease (MMD) stages using Digital Subtraction Angiography (DSA) scans. This AI approach achieves 95.78% accuracy, aiding prompt clinical assessment and patient care.

Area of Science:

  • Medical Imaging Analysis
  • Artificial Intelligence in Medicine
  • Neurology

Background:

  • Accurate and timely assessment of moyamoya disease (MMD) is crucial for preventing life-threatening complications.
  • Digital Subtraction Angiography (DSA) is a key imaging modality for evaluating MMD progression.

Purpose of the Study:

  • To develop and validate a novel deep learning model for automated MMD staging using DSA sequences.
  • To enhance the accuracy and efficiency of MMD diagnosis in clinical settings.

Main Methods:

  • A Pseudo-Three-Dimensional Residual Network (P3D ResNet) was designed to process spatial and temporal information from DSA sequences.
  • Decoupled 3D dilated convolutions were employed in spatial and temporal domains to enhance feature extraction.
  • DSA data was augmented and split into training, verification, and test sets (6:2:2 ratio) for model development and evaluation.

Main Results:

  • The P3D ResNet model achieved a high accuracy of 95.78% in identifying MMD stages (mild, moderate, severe).
  • The model demonstrated efficient processing of spatial and temporal features within DSA images.
  • The architecture effectively increased the receptive field while preserving vessel features.

Conclusions:

  • The proposed P3D ResNet offers a highly accurate and clinically feasible method for MMD staging.
  • This AI-driven approach can significantly aid clinicians in the prompt and precise assessment of moyamoya disease.
  • The P3D ResNet shows promise for improving patient outcomes through early and accurate diagnosis.

Related Concept Videos